Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation (LiverTOL-Dx Trial)

Sanchez Fueyo, Alberto (Primary Investigator)
Peacock, Janet (Co-Investigator)
Rebollo-Mesa, Irene (Co-Investigator)

Project: Research

Status	Finished
Effective start/end date	1/04/2015 → 31/03/2021

Collaborative partners

King's College London (lead)
Newcastle upon Tyne Hospitals NHS Foundation Trust
Royal Free London NHS Foundation Trust
KCH King's College Hospital NHS Foundation Trust
University of Edinburgh
Addenbrookes NHS Trust
Leeds Teaching Hospitals NHS Trust
University Hospitals Birmingham NHS Foundation Trust

Funding

NIHR National Institute For Health & Care Research: £1,671,143.00